Osteopore Limited
Osteopore Limited
Your view on OSX.AX
Overview
What the company does, where it operates, and who runs it.
About Osteopore Limited
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Yujing Lim
- Headquarters
- Level 5, 191 St. Georges Terrace, Perth, WA, AU
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Yujing Lim
- Headquarters
- Level 5, 191 St. Georges Terrace, Perth, WA, AU
Established in Singapore in 2003, Osteopore Limited focuses on engineering, manufacturing, and globally commercializing bioresorbable polymer implants. These advanced devices are utilized in neurosurgical, orthopedic, and maxillofacial operations throughout Singapore, Australia, and other international regions.
The company's core innovation involves employing 3D printing with bioresorbable materials to create custom, micro-structured scaffolds specifically designed to foster bone regeneration.
Its product portfolio includes Osteoplug, a resorbable implant for sealing trephination burr holes during neurosurgery, and Osteomesh, another resorbable implant used in craniofacial surgery to mend various fractures, including orbital floor injuries, and to fill surgical voids.
Additionally, Osteopore has forged a collaborative partnership with Livingstone Health Holding Limited to jointly pioneer new products and applications for bone and tissue regeneration.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Osteopore Limited. Starting points for Osteopore Limited: EPS -AUD 0.0078, beta -0.02 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Osteopore Limited. Osteopore Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Osteopore Limited. Trailing twelve-month EPS for Osteopore Limited stands at -AUD 0.0078. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Osteopore Limited. Osteopore Limited has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| 1AD.AXAdAlta Limited | Healthcare | Biotechnology | — | ||
| ACR.AXAcrux Limited | Healthcare | Biotechnology | — | ||
| ANR.AXAnatara Lifesciences Ltd | Healthcare | Biotechnology | — | ||
| BIT.AXBiotron Limited | Healthcare | Biotechnology | — | ||
| CTQ.AXCareteq Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| EXL.AXElixinol Wellness Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| OAK.AXOakridge International Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| TD1.AXTALi Digital Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| DGENDeltagen Inc. | Healthcare | OTC | $3,859 | ||
| DXRDaxor Corporation | Healthcare | NASDAQ | $46.8M | ||
| ECIAEncision Inc. | Healthcare | OTC | $1.9M | ||
| EKTAFElekta AB (publ) | Healthcare | OTC | $2.2B | ||
| EKTAYElekta AB (publ) | Healthcare | OTC | $2.5B | ||
| EMBCEmbecta Corp. | Healthcare | NASDAQ | $345.1M | ||
| ESLOFEssilorLuxottica S.A. | Healthcare | OTC | $128.6B | ||
| ESLOYEssilorLuxottica S.A. | Healthcare | OTC | $129.8B | ||
| FEMYFemasys Inc. | Healthcare | NASDAQ | $9.6M | ||
| FPH.AXFisher & Paykel Healthcare Corporation Limited | Healthcare | ASX | — | ||
| FSPKFFisher & Paykel Healthcare Corporation Limited | Healthcare | OTC | $14.2B | ||
| GRRMFGerresheimer AG | Healthcare | OTC | $691.8M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Osteopore Limited. Coverage tracks Osteopore Limited within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Osteopore Limited.